DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Giles AR, Rivard GE, Teitel J, Walker I.
Surveillance for factor VIII inhibitor development in the Canadian Hemophilia A population following the widespread introduction of recombinant factor VIII replacement therapy.
Transfus Sci 1998;
19 (2) 139-148
We do not assume any responsibility for the contents of the web pages of other providers.